MGO One Seven LLC Acquires 3,943 Shares of STERIS plc $STE

MGO One Seven LLC lifted its holdings in shares of STERIS plc (NYSE:STE) by 38.7% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 14,119 shares of the medical equipment provider’s stock after buying an additional 3,943 shares during the period. MGO One Seven LLC’s holdings in STERIS were worth $3,579,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also modified their holdings of the business. Trust Co. of Vermont raised its stake in STERIS by 30.2% during the fourth quarter. Trust Co. of Vermont now owns 164 shares of the medical equipment provider’s stock worth $42,000 after acquiring an additional 38 shares in the last quarter. Magnolia Capital Advisors LLC boosted its stake in shares of STERIS by 1.2% in the 3rd quarter. Magnolia Capital Advisors LLC now owns 3,588 shares of the medical equipment provider’s stock valued at $888,000 after purchasing an additional 41 shares in the last quarter. Colonial Trust Co SC boosted its stake in shares of STERIS by 0.3% in the 3rd quarter. Colonial Trust Co SC now owns 12,329 shares of the medical equipment provider’s stock valued at $3,051,000 after purchasing an additional 42 shares in the last quarter. Geneos Wealth Management Inc. grew its holdings in shares of STERIS by 34.9% during the 2nd quarter. Geneos Wealth Management Inc. now owns 174 shares of the medical equipment provider’s stock valued at $42,000 after purchasing an additional 45 shares during the last quarter. Finally, Fifth Third Bancorp grew its holdings in shares of STERIS by 1.6% during the 3rd quarter. Fifth Third Bancorp now owns 2,953 shares of the medical equipment provider’s stock valued at $731,000 after purchasing an additional 46 shares during the last quarter. 94.69% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on STE shares. Weiss Ratings downgraded shares of STERIS from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Thursday, April 16th. Wall Street Zen cut shares of STERIS from a “strong-buy” rating to a “buy” rating in a research note on Sunday, April 26th. Five analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, STERIS presently has a consensus rating of “Moderate Buy” and a consensus target price of $275.20.

STERIS Trading Down 2.9%

Shares of NYSE STE opened at $207.40 on Friday. The firm has a 50 day moving average price of $224.30 and a two-hundred day moving average price of $244.27. The stock has a market cap of $20.34 billion, a P/E ratio of 28.93 and a beta of 0.95. STERIS plc has a 52-week low of $195.14 and a 52-week high of $269.44. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.75 and a current ratio of 2.48.

STERIS (NYSE:STE) last issued its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 EPS for the quarter, hitting analysts’ consensus estimates of $2.53. STERIS had a net margin of 12.15% and a return on equity of 14.34%. The company’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter last year, the firm earned $2.32 EPS. As a group, equities analysts forecast that STERIS plc will post 10.22 EPS for the current year.

STERIS Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 8th will be issued a dividend of $0.63 per share. The ex-dividend date of this dividend is Monday, June 8th. This represents a $2.52 annualized dividend and a yield of 1.2%. STERIS’s payout ratio is presently 35.15%.

Insider Activity at STERIS

In other news, Director Cynthia L. Feldmann sold 3,098 shares of the stock in a transaction dated Thursday, March 5th. The stock was sold at an average price of $237.21, for a total value of $734,876.58. Following the completion of the sale, the director owned 705 shares of the company’s stock, valued at approximately $167,233.05. This represents a 81.46% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 1.07% of the company’s stock.

STERIS Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.